XML 73 R61.htm IDEA: XBRL DOCUMENT
v3.22.1

INTANGIBLE ASSETS AND GOODWILL - Narrative (Details) |  |  |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Oct. 01, 2021 USD ($) | Jun. 30, 2021 USD ($) | Mar. 31, 2021 USD ($) | Mar. 31, 2022 USD ($) reporting_unit | Mar. 31, 2021 USD ($) | Dec. 31, 2021 USD ($)
Goodwill [Line Items] |  |  |  |  |  |
Impairment of intangible assets |  |  |  | $ 8,000,000 | $ 148,000,000 |
Fair value of reporting value, greater than its carrying value |  | 45.00% | 40.00% |  | 40.00% |
Goodwill impairment |  | $ 0 | $ 0 |  |  | $ 469,000,000
Accumulated goodwill impairment charges |  |  |  | $ 4,180,000,000 |  |
Ortho Dermatologics |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Goodwill impairment |  |  |  |  |  | 469,000,000
Number of reporting units | reporting_unit |  |  |  | 2 |  |
Reporting Units Excluding Ortho Dermatologics |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Goodwill impairment |  |  |  |  |  | $ 0
Ortho Dermatologics Reporting Unit |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Reporting unit, impairment test, long-term growth rate | 1.00% |  | 1.00% | 1.00% | 1.00% |
Reporting unit, impairment test, estimated cash flows, discount rate | 9.00% |  |  | 9.00% |  |
Fair value of reporting value, greater than its carrying value | 10.00% |  |  | 2.00% |  |
Goodwill impairment | $ 0 |  | $ 469,000,000 | $ 0 |  |
Minimum |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Reporting unit, impairment test, long-term growth rate |  | 2.00% | 1.00% |  | 1.00% |
Reporting unit, impairment test, estimated cash flows, discount rate |  | 7.00% | 11.00% |  | 11.00% |
Minimum | Ortho Dermatologics Reporting Unit |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Reporting unit, impairment test, estimated cash flows, discount rate |  |  | 9.00% |  | 9.00% |
Maximum |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Reporting unit, impairment test, long-term growth rate |  | 3.00% | 3.00% |  | 3.00% |
Reporting unit, impairment test, estimated cash flows, discount rate |  | 10.00% | 12.25% |  | 12.25% |
Maximum | Ortho Dermatologics Reporting Unit |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Reporting unit, impairment test, estimated cash flows, discount rate |  |  | 10.00% |  | 10.00% |
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Amoun |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Impairment of intangible assets |  |  |  |  | $ 68,000,000 |
Product brands |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Impairment of intangible assets |  |  |  | 4,000,000 | 71,000,000 |
Discontinued Product Lines |  |  |  |  |  |
Goodwill [Line Items] |  |  |  |  |  |
Impairment of intangible assets |  |  |  | $ 4,000,000 | $ 9,000,000 |

X
- Definition Reporting Unit, Impairment Test, Estimated Cash Flows, Discount Rate + References No definition available. + Details
Name: | bhc_ReportingUnitImpairmentTestEstimatedCashFlowsDiscountRate
Namespace Prefix: | bhc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Reporting Unit, Impairment Test, Long-Term Growth Rate + References No definition available. + Details
Name: | bhc_ReportingUnitImpairmentTestLongTermGrowthRate
Namespace Prefix: | bhc_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (h) -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 + Details
Name: | us-gaap_GoodwillImpairedAccumulatedImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266 + Details
Name: | us-gaap_GoodwillImpairmentLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_GoodwillLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275 + Details
Name: | us-gaap_ImpairmentOfIntangibleAssetsFinitelived
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment. + References No definition available. + Details
Name: | us-gaap_NumberOfReportingUnits
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of fair value of reporting unit in excess of carrying amount. + References No definition available. + Details
Name: | us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=bhc_OrthoDermatologicsSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ReportingUnitAxis=bhc_ReportingUnitsExcludingOrthoDermatologicsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ReportingUnitAxis=bhc_OrthoDermatologicsReportingUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bhc_AmounPharmaceuticalCompanySAEMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhc_ProductBrandsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=bhc_DiscontinuedProductLinesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |